Artificial Intelligence Helps Diagnose Parkinson’s
Researchers used artificial intelligence techniques to estimate parameters such as step length, width, and velocity to diagnose Parkinson's.
Category: Parkinson’s Disease
Parkinson’s Disease
Latest
Parkinson’s Disease
Latest
Tampa General Hospital and USF Health Neurosurgeons Provide Focused Ultrasound Technology for First Time
Focused ultrasound offers treatment for people suffering from essential tremor, Parkinson's disease, and other neurological disorders.
Parkinson’s Disease
Latest
FDA Approves SenSight Directional Lead System for DBS Therapy
Medtronic plc announces the US Food and Drug Administration (FDA) approval and first US implants of the SenSight Directional Lead System used for Deep Brain Stimulation (DBS) therapy.
Physical Therapy for Parkinson’s Disease
Alexandra Taratuski, PT, DPT, explains how to optimize your physical therapy treatment sessions and use exercise as a form of medication to overcome symptoms of Parkinson’s disease, in this feature for the Fall 2020 Rehab Management Product Guide.
Read More
Beep Beep, Beep Beep … Bad for Brains
Researchers looking at the brainstems of children and young adults exposed lifelong to air pollution in Mexico City have discovered disturbing evidence of neurological harm. Their study is published in Environmental Research.
Read More
How Spinal Cord Stimulation Could Aid Parkinson’s Symptoms
Spinal cord stimulation (SCS) measurably decreased pain and reduced motor symptoms of Parkinson’s disease, both as a singular therapy and as a “salvage therapy” after deep brain stimulation (DBS) therapies were ineffective, according to researchers from the United States and Japan, in Bioelectronic Medicine.
Read More
Stem Cells Aim to Repair Parkinson’s-Damaged Circuits in Mouse Brains
University of Wisconsin-Madison researchers demonstrate a proof-of-concept stem cell treatment in a mouse model of Parkinson’s disease. They suggest that neurons derived from stem cells can integrate well into the correct regions of the brain, connect with native neurons and restore motor functions.
Read More
Cala Trio Essential Tremor Therapy Safe, Effective in Real-World Conditions, Per Data
Representatives from Cala Health Inc recently presented data demonstrating that Cala Trio therapy is safe and effective in improving tremors in patients with essential tremor (ET) when used at home, unsupervised, and under real-world conditions.
Read More
APDA Funds $1.4M in Grants for 2020-2021
The American Parkinson Disease Association (APDA) reports the awarding of $1.4 million in grants to support Parkinson’s disease (PD) research for the 2020-2021 funding year.
Read More
Parkinson’s Foundation Expands Its Virtual Programs to Ensure Access to Resources During Pandemic
The Parkinson’s Foundation announces expanded virtual programs to support the Parkinson’s disease (PD) community during the ongoing COVID-19 pandemic.
Read More
Michael J. Fox Foundation Relaunches Monthly Parkinson’s Podcast
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announces the re-launch of its Parkinson’s Podcast — a monthly conversation hosted by Larry Gifford and designed to help people with Parkinson’s disease (PD) and their care partners stay informed on the latest topics in research and care.
Read More
6th Annual World Brain Day Focuses on Ending Parkinson’s Disease
The 6th annual World Brain Day on July 22 is dedicated to raising awareness for Parkinson’s Disease, according to a news release.
Read More
Parkinson’s Genetic Testing Study Brings Surprising Results
Preliminary results from the PD GENEration: Mapping the Future of Parkinson’s Disease pilot study demonstrate the feasibility to conduct comprehensive genetic testing and genetic counseling for the larger Parkinson’s disease (PD) community, as well as the identification of rare genetic mutation carriers linked to PD.
Read More
Fox Foundation Data Set Reveals Effects of COVID-19 on Parkinson’s Patients
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has released results from a self-reported data set detailing the lived experience of the coronavirus disease (COVID-19) pandemic on the Parkinson’s disease (PD) community.
Read More
Glencroft Center Debuts ZoeLife Immersion Program for Parkinson’s Patients
The Glencroft Center for Modern Aging, located in Glendale, Ariz, launches the ZoeLife Parkinson’s Immersion Program (PIP), designed to slow disease progression, increase independence, and reduce fall risks for senior-aged residents diagnosed with Parkinson’s disease.
Read More
Target This to Help Improve Essential Tremor Treatment
Recently developed MRI techniques used to more precisely target a small area in the brain linked to Parkinson’s disease and essential tremor may lead to better outcomes without surgery and with less risk of negative effects, a new study led by UT Southwestern researchers suggests.
Read More
ESPN Founder Bill Rasmussen Joins Michael J. Fox Foundation as Ambassador
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announces that Bill Rasmussen has joined its team to help speed a cure for Parkinson’s disease.
Read More
Drug for Parkinson’s ‘Off’ Days Receives FDA Approval
The US Food and Drug Administration has approved Kynmobi from Sunovion Pharmaceuticals Inc, formulated to treat “off” time, when Parkinson’s disease (PD) symptoms are not well controlled with oral medication.
Read More